2023 Was a troublesome year with the biopharma field, with quite a few corporations downsizing and restructuring their workforces to stay afloat. There are signs of Restoration, as mergers and acquisitions picked up across the pharmaceutical and everyday living sciences market in the latter Section of 2023 and possess continued https://sites.google.com/view/bio-sites/blog